Role of endothelial progenitor cells and inflammatory cytokines in healing of diabetic foot ulcers

PLoS ONE

Volumn 8, Issue 12, 2013, Pages

  Tecilazich, Francesco ^a   Dinh, Thanh ^a   Pradhan Nabzdyk, Leena ^a   Leal, Ermelindo ^a,b   Tellechea, Ana ^a,b   Kafanas, Antonios ^a   Gnardellis, Charalambos ^c   Magargee, Mary L ^a   Dejam, Andre ^a   Toxavidis, Vasilis ^d   Tigges, John C ^d   Carvalho, Eugenia ^a,b   Lyons, Thomas E ^a   Veves, Aristidis ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF COIMBRA   (Portugal)

^c TECHNOLOGICAL EDUCATIONAL INSTITUTE OF PATRAS   (Greece)

^d HARVARD STEM CELL INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; GAMMA INTERFERON; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 1ALPHA; INTERLEUKIN 8; MACROPHAGE DERIVED CHEMOKINE; STEM CELL FACTOR; STROMAL CELL DERIVED FACTOR 1; TISSUE PLASMINOGEN ACTIVATOR; TISSUE PLASMINOGEN ACTIVATOR 1; UNCLASSIFIED DRUG; VASCULAR CELL ADHESION MOLECULE 1; VASCULOTROPIN RECEPTOR 2;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL COUNT; CLINICAL ARTICLE; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DIABETIC FOOT; DIABETIC PATIENT; ENDOTHELIAL PROGENITOR CELL; FEMALE; FLOW CYTOMETRY; FLOW MEDIATED VASODILATION; HUMAN; HUMAN CELL; HUMAN TISSUE; MALE; MOUSE; MOUSE MODEL; NONHUMAN; OXYGEN SATURATION; PHENOTYPE; PROSPECTIVE STUDY; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; RABBIT MODEL; RISK REDUCTION; VASODILATATION; WOUND HEALING;

ADULT; AGED; ANIMALS; CASE-CONTROL STUDIES; CYTOKINES; DIABETIC FOOT; ENDOTHELIAL CELLS; FEMALE; HUMANS; INFLAMMATION; INFLAMMATION MEDIATORS; MALE; MICE; MICE, INBRED C57BL; MIDDLE AGED; RABBITS; STEM CELLS; WOUND HEALING;

EID: 84892726746     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0083314     Document Type: Article

References (37)

1. Ramsey SD, Newton K, Blough D, McCulloch DK, Sandhu N et al. (1999) Incidence, outcomes, and cost of foot ulcers in patients with diabetes. Diabetes Care 22: 382-387. doi:10.2337/diacare.22.3.382. PubMed: 10097914.
2. Falanga V (2005) Wound healing and its impairment in the diabetic foot. Lancet 366: 1736-1743. doi:10.1016/S0140-6736(05)67700-8. PubMed: 16291068.
3. Dinh T, Tecilazich F, Kafanas A, Doupis J, Gnardellis C et al. (2012) Mechanisms involved in the development and healing of diabetic foot ulceration. Diabetes 61: 2937-2947. doi:10.2337/db12-0227. PubMed: 22688339.
4. Takahashi T, Kalka C, Masuda H, Chen D, Silver M et al. (1999) Ischemia- and cytokine-induced mobilization of bone marrow-derived endothelial progenitor cells for neovascularization. Nat Med 5: 434-438. doi:10.1038/7434. PubMed: 10202935.
5. Werner N, Kosiol S, Schiegl T, Ahlers P, Walenta K et al. (2005) Circulating endothelial progenitor cells and cardiovascular outcomes. N Engl J Med 353: 999-1007. doi:10.1056/NEJMoa043814. PubMed: 16148285.
6. Fadini GP, Sartore S, Albiero M, Baesso I, Murphy E et al. (2006) Number and function of endothelial progenitor cells as a marker of severity for diabetic vasculopathy. Arterioscler Thromb Vasc Biol 26: 2140-2146. doi:10.1161/01.ATV.0000237750.44469.88. PubMed: 16857948.
7. Fadini GP, Miorin M, Facco M, Bonamico S, Baesso I et al. (2005) Circulating endothelial progenitor cells are reduced in peripheral vascular complications of type 2 diabetes mellitus. J Am Coll Cardiol 45: 1449-1457. doi:10.1016/j.jacc.2004.11.067. PubMed: 15862417.
8. van Ark J, Moser J, Lexis CP, Bekkema F, Pop I et al. (2012) Type 2 diabetes mellitus is associated with an imbalance in circulating endothelial and smooth muscle progenitor cell numbers. Diabetologia 55: 2501-2512. doi:10.1007/s00125-012-2590-5. PubMed: 22648662.
9. Huang P, Li S, Han M, Xiao Z, Yang R et al. (2005) Autologous transplantation of granulocyte colony-stimulating factor-mobilized peripheral blood mononuclear cells improves critical limb ischemia in diabetes. Diabetes Care 28: 2155-2160. doi:10.2337/diacare.28.9.2155. PubMed: 16123483.
10. Pham H, Armstrong DG, Harvey C, Harkless LB, Giurini JM et al. (2000) Screening techniques to identify people at high risk for diabetic foot ulceration: a prospective multicenter trial. Diabetes Care 23: 606-611. doi:10.2337/diacare.23.5.606. PubMed: 10834417.
11. American Diabetes Association (1999) Consensus Development Conference on Diabetic Foot Wound Care: 7-8 April 1999, Boston, Massachusetts. American Diabetes. Association - Diabetes Care 22: 1354-1360. doi:10.2337/diacare.22.8. 1354.
12. Veves A, Akbari CM, Primavera J, Donaghue VM, Zacharoulis D et al. (1998) Endothelial dysfunction and the expression of endothelial nitric oxide synthetase in diabetic neuropathy, vascular disease, and foot ulceration. Diabetes 47: 457-463. doi:10.2337/diabetes.47.3.457. PubMed: 9519754.
13. Corretti MC, Anderson TJ, Benjamin EJ, Celermajer D, Charbonneau F et al. (2002) Guidelines for the ultrasound assessment of endothelial-dependent flow-mediated vasodilation of the brachial artery: a report of the International Brachial Artery Reactivity Task Force. J Am Coll Cardiol 39: 257-265. doi:10.1016/S0735-1097(02)81153-6. PubMed: 11788217.
14. Greenman RL, Panasyuk S, Wang X, Lyons TE, Dinh T et al. (2005) Early changes in the skin microcirculation and muscle metabolism of the diabetic foot. Lancet 366: 1711-1717. doi:10.1016/S0140-6736(05)67696-9. PubMed: 16291064.
15. Pradhan L, Cai X, Wu S, Andersen ND, Martin M et al. (2011) Gene expression of pro-inflammatory cytokines and neuropeptides in diabetic wound healing. J Surg Res 167: 336-342. doi:10.1016/j.jss.2009.09.012. PubMed: 20070982.
16. Ceradini DJ, Kulkarni AR, Callaghan MJ, Tepper OM, Bastidas N et al. (2004) Progenitor cell trafficking is regulated by hypoxic gradients through HIF-1 induction of SDF-1. Nat Med 10: 858-864. doi:10.1038/nm1075. PubMed: 15235597.
17. Fadini GP, Sartore S, Agostini C, Avogaro A (2007) Significance of endothelial progenitor cells in subjects with diabetes. Diabetes Care 30: 1305-1313. doi:10.2337/dc06-2305. PubMed: 17277037.
18. Fadini GP, Losordo D, Dimmeler S (2012) Critical reevaluation of endothelial progenitor cell phenotypes for therapeutic and diagnostic use. Circ Res 110: 624-637. doi:10.1161/CIRCRESAHA.111.243386. PubMed: 22343557.
19. Bertolini F, Mancuso P, Braidotti P, Shaked Y, Kerbel RS (2009) The multiple personality disorder phenotype(s) of circulating endothelial cells in cancer. Biochim Biophys Acta 1796: 27-32. PubMed: 19406208.
20. Zerbini G, Maestroni A, Palini A, Tremolada G, Lattanzio R et al. (2012) Endothelial progenitor cells carrying monocyte markers are selectively abnormal in type 1 diabetic patients with early retinopathy. Diabetes 61: 908-914. doi:10.2337/db11-1197. PubMed: 22338095.
21. Blann AD, Pretorius A (2006) Circulating endothelial cells and endothelial progenitor cells: two sides of the same coin, or two different coins? Atherosclerosis 188: 12-18. doi:10.1016/j.atherosclerosis.2005.12.024. PubMed: 16487972.
22. Liao YF, Chen LL, Zeng TS, Li YM, Fan Y et al. (2010) Number of circulating endothelial progenitor cells as a marker of vascular endothelial function for type 2 diabetes. Vasc Med 15: 279-285. doi: 10.1177/ 1358863X10367537. PubMed: 20511292.
23. Flammer AJ, Gössl M, Li J, Matsuo Y, Reriani M et al. (2012) Patients with an HbA1c in the prediabetic and diabetic range have higher numbers of circulating cells with osteogenic and endothelial progenitor cell markers. J Clin Endocrinol Metab 97: 4761-4768. doi:10.1210/jc.2012-2642. PubMed: 23015657.
24. Timmermans F, Van Hauwermeiren F, De Smedt M, Raedt R, Plasschaert F et al. (2007) Endothelial outgrowth cells are not derived from CD133+ cells or CD45+ hematopoietic precursors. Arterioscler Thromb Vasc Biol 27: 1572-1579. doi:10.1161/ATVBAHA.107.144972. PubMed: 17495235.
25. Fadini GP, Sartore S, Schiavon M, Albiero M, Baesso I et al. (2006) Diabetes impairs progenitor cell mobilisation after hindlimb ischaemiareperfusion injury in rats. Diabetologia 49: 3075-3084. doi:10.1007/s00125-006-0401-6. PubMed: 17072586.
26. Gallagher KA, Liu ZJ, Xiao M, Chen H, Goldstein LJ et al. (2007) Diabetic impairments in NO-mediated endothelial progenitor cell mobilization and homing are reversed by hyperoxia and SDF-1 alpha. J Clin Invest 117: 1249-1259. doi:10.1172/JCI29710. PubMed: 17476357.
27. Bermudez DM, Xu J, Herdrich BJ, Radu A, Mitchell ME et al. (2011) Inhibition of stromal cell-derived factor-1alpha further impairs diabetic wound healing. J Vasc Surg 53: 774-784. doi:10.1016/j.jvs.2010.10.056. PubMed: 21211927.
28. Heissig B, Hattori K, Dias S, Friedrich M, Ferris B et al. (2002) Recruitment of stem and progenitor cells from the bone marrow niche requires MMP-9 mediated release of kit-ligand. Cell 109: 625-637. doi: 10.1016/S0092-8674(02)00754-7. PubMed: 12062105.
29. Nishimura Y, Ii M, Qin G, Hamada H, Asai J et al. (2012) CXCR4 antagonist AMD3100 accelerates impaired wound healing in diabetic mice. J Invest Dermatol 132: 711-720. doi:10.1038/jid.2011.356. PubMed: 22048734.
30. Pepys MB, Hirschfield GM (2003) C-reactive protein: a critical update. J Clin Invest 111: 1805-1812. doi:10.1172/JCI18921. PubMed: 12813013.
31. Gahring LC, Buckley A, Daynes RA (1985) Presence of epidermalderived thymocyte activating factor/interleukin 1 in normal human stratum corneum. J Clin Invest 76: 1585-1591. doi:10.1172/JCI112141. PubMed: 2997285.
32. Barrientos S, Stojadinovic O, Golinko MS, Brem H, Tomic-Canic M (2008) Growth factors and cytokines in wound healing. Wound Repair Regen 16: 585-601. doi:10.1111/j.1524-475X.2008.00410.x. PubMed: 19128254.
33. Beidler SK, Douillet CD, Berndt DF, Keagy BA, Rich PB et al. (2009) Inflammatory cytokine levels in chronic venous insufficiency ulcer tissue before and after compression therapy. J Vasc Surg 49: 1013-1020. doi: 10.1016/j.jvs.2008.11.049. PubMed: 19341889.
34. Khaodhiar L, Dinh T, Schomacker KT, Panasyuk SV, Freeman JE et al. (2007) The use of medical hyperspectral technology to evaluate microcirculatory changes in diabetic foot ulcers and to predict clinical outcomes. Diabetes Care 30: 903-910. doi:10.2337/dc06-2209. PubMed: 17303790.
35. Albiero M, Menegazzo L, Boscaro E, Agostini C, Avogaro A et al. (2011) Defective recruitment, survival and proliferation of bone marrow-derived progenitor cells at sites of delayed diabetic wound healing in mice. Diabetologia 54: 945-953. doi:10.1007/s00125-010-2007-2. PubMed: 21165593.
36. Saito H, Yamamoto Y, Yamamoto H (2012) Diabetes alters subsets of endothelial progenitor cells that reside in blood, bone marrow, and spleen. Am J Physiol Cell Physiol 302: C892-C901. doi:10.1152/ajpcell.00380.2011. PubMed: 22159079.
37. Schömig K, Busch G, Steppich B, Sepp D, Kaufmann J et al. (2006) Interleukin-8 is associated with circulating CD133+ progenitor cells in acute myocardial infarction. Eur Heart J 27: 1032-1037. PubMed: 16455670.